MMP-2 Responsive Peptide Hydrogel-Based Nanoplatform for Multimodal Tumor Therapy

References

• Adam F, Manju S, Dorothy L, et al. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey. Lancet Oncol. 2021;22(10):1367–1377. doi:10.1016/S1470-2045(21)00463-0
   PubMed Web of Science ®Google Scholar
• Yi X, Zeng W, Wang C, et al. A step-by-step multiple stimuli-responsive metal-phenolic network prodrug nanoparticles for chemotherapy. Nano Res. 2021;15(2):1205–1212. doi:10.1007/s12274-021-3626-2
   Web of Science ®Google Scholar
• Lu Y, Aimetti AA, Langer R, et al. Bioresponsive materials. Nature Rev Mater. 2016;2(1):16075. doi:10.1038/natrevmats.2016.75
   Web of Science ®Google Scholar
• Tan T, Wang H, Cao H, et al. Deep tumor-penetrated nanocages improve accessibility to cancer stem cells for photothermal-chemotherapy of breast cancer metastasis. Adv Sci. 2018;5(12):1801012. doi:10.1002/advs.201801012
   Web of Science ®Google Scholar
• Jiang Y, Li J, Zhen X, et al. Dual-peak absorbing semiconducting copolymer nanoparticles for first and second near-infrared window photothermal therapy: a comparative study. Ad. Mater. 2018;30(14):e1705980. doi:10.1002/adma.201705980
   PubMed Web of Science ®Google Scholar
• Chen F, Zang Z, Chen Z, et al. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials. 2019;214:119226. doi:10.1016/j.biomaterials.2019.119226
   PubMed Web of Science ®Google Scholar
• Sanmamed MF, Chen L. A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell. 2018;175(2):313–326. doi:10.1016/j.cell.2018.09.035
   PubMed Web of Science ®Google Scholar
• Yang Q, Peng J, Shi K, et al. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy. J Control Release. 2019;308:29–43. doi:10.1016/j.jconrel.2019.06.031
   PubMed Web of Science ®Google Scholar
• Rosenblum D, Joshi N, Tao W, et al. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9(1):1410. doi:10.1038/s41467-018-03705-y
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnol. 2015;33(9):941–951. doi:10.1038/nbt.3330
   PubMed Web of Science ®Google Scholar
• Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Med. 2018;24(5):541–550. doi:10.1038/s41591-018-0014-x
   PubMed Web of Science ®Google Scholar
• Tian G, Zhang X, Gu Z, et al. Recent advances in up conversion nanoparticles-based multifunctional nanocomposites for combined cancer therapy. Adv Mater. 2015;27(47):7692–7712. doi:10.1002/adma.201503280
   PubMed Web of Science ®Google Scholar
• Li J, Zhang C, Gong S, et al. A nanoscale photothermal agent based on a metal-organic coordination polymer as a drug-loading framework for effective combination therapy. Acta Biomater. 2019;94:435–446. doi:10.1016/j.actbio.2019.06.014
   PubMed Web of Science ®Google Scholar
• Fan W, Yung B, Huang P, et al. Nanotechnology for multimodal synergistic cancer therapy. Chem Rev. 2017;117(22):13566–13638. doi:10.1021/acs.chemrev.7b00258
   PubMed Web of Science ®Google Scholar
• Singh A, Peppas NA. Hydrogels and scaffolds for immunomodulation. Adv Mater. 2014;26(38):6530–6541. doi:10.1002/adma.201402105
   PubMed Web of Science ®Google Scholar
• Wang F, Xu D, Su H, et al. Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy. Sci Adv. 2020;6:12.
   Web of Science ®Google Scholar
• Sharpe AH, Wherry EJ, Ahmed R, et al. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8(3):239–245. doi:10.1038/ni1443
   PubMed Web of Science ®Google Scholar
• Hu H, Qi Q, Dong Z, et al. Albumin coated trimethyl chitosan-based targeting delivery platform for photothermal/chemo-synergistic cancer therapy. Carbohydr Polym. 2020;241:116335. doi:10.1016/j.carbpol.2020.116335
   PubMed Web of Science ®Google Scholar
• George J, Hsu -C-C, Nguyen L, et al. Neural tissue engineering with structured hydrogels in CNS models and therapies. Biotechnol Adv. 2020;42:107370. doi:10.1016/j.biotechadv.2019.03.009
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang D, Qiao ZY, et al. A peptide-network weaved nanoplatform with tumor microenvironment responsiveness and deep tissue penetration capability for cancer therapy. Adv Mater. 2015;27(34):5034–5042. doi:10.1002/adma.201501502
   PubMed Web of Science ®Google Scholar
• Eskandari S, Guerin T, Toth I, et al. Recent advances in self-assembled peptides: implications for targeted drug delivery and vaccine engineering. Adv Drug Delivery Rev. 2017;110–111:169–187. doi:10.1016/j.addr.2016.06.013
   PubMed Web of Science ®Google Scholar
• Wang Y, Ye F, Liang Y, et al. Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies. Br J Cancer. 2021;125(8):1056–1067. doi:10.1038/s41416-021-01424-8
   PubMed Web of Science ®Google Scholar
• Cheng K, Ding Y, Zhao Y, et al. Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy. Nano Lett. 2018;18(5):3250–3258. doi:10.1021/acs.nanolett.8b01071
   PubMed Web of Science ®Google Scholar
• Chau Y, Luo Y, Cheung AC, et al. Incorporation of a matrix metalloproteinase-sensitive substrate into self-assembling peptides - a model for biofunctional scaffolds. Biomaterials. 2008;29(11):1713–1719. doi:10.1016/j.biomaterials.2007.11.046
   PubMed Web of Science ®Google Scholar
• Huang L, Li Y, Du Y, et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat Commun. 2019;10(1):4871. doi:10.1038/s41467-019-12771-9
   PubMed Web of Science ®Google Scholar
• Su YL, Hu SH. Functional nanoparticles for tumor penetration of therapeutics. Pharmaceutics. 2018;10(4):193. doi:10.3390/pharmaceutics10040193
   PubMed Web of Science ®Google Scholar
• Hung CC, Huang WC, Lin YW, et al. Active tumor permeation and uptake of surface charge-switchable theranostic nanoparticles for imaging-guided photothermal/chemo combinatorial therapy. Theranostics. 2017;7(3):559–560. doi:10.7150/thno.18728
   PubMed Web of Science ®Google Scholar
• Chau WK, Ip CK, Mak AS, et al. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-binding cassette G2 signaling. Oncogene. 2013;32(22):2767–2781. doi:10.1038/onc.2012.290
   PubMed Web of Science ®Google Scholar
• Kepp O, Zitvogel L, Kroemer G. Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade. Oncoimmunology. 2019;8(10):e1637188. doi:10.1080/2162402X.2019.1637188
   PubMed Web of Science ®Google Scholar
• Sun F, Cui L, Li T, et al. Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma. J Recept Signal Transduct Res. 2019;39(3):208–214. doi:10.1080/10799893.2019.1655050
   PubMed Web of Science ®Google Scholar
• Chaiyasan W, Srinivas SP, Niamprem P, et al. Penetration of hydrophilic sulforhodamine B across the porcine cornea ex-vivo. Int J Appl Pharm. 2018;10(6):94. doi:10.22159/ijap.2018v10i6.28505
   PubMedGoogle Scholar
• Cerbelli B, Pernazza A, Botticelli A, et al. PD-L1 expression in TNBC: a predictive biomarker of response to neoadjuvant chemotherapy. Biomed Res. Int. 2017;2017:1750925. doi:10.1155/2017/1750925
   PubMed Web of Science ®Google Scholar
• Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27(1):109–118. doi:10.1038/cr.2016.151
   PubMed Web of Science ®Google Scholar
• Suh YJ, Park JH, Jeon JH, et al. Extrapleural solitary fibrous tumor of the thyroid gland: a case report and review of literature. World J Clin Cases. 2020;8(4):782–789. doi:10.12998/wjcc.v8.i4.782
   PubMed Web of Science ®Google Scholar
• Xiong J, Yang LY. Effects of alkaloid sinomenine on levels of IFN‑γ, IL‑1β, TNF‑α and IL‑6 in a rat renal allograft model. Immunotherapy. 2012;4(8):7. doi:10.2217/imt.12.80
   Web of Science ®Google Scholar
• De Vlaeminck Y, Bonelli S, Awad RM, et al. Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development. Cancers. 2020;12(12):3582. doi:10.3390/cancers12123582
   PubMed Web of Science ®Google Scholar
• Wang T, Wang D, Yu H, et al. Intracellularly acid-switchable multifunctional micelles for combinational photo/chemotherapy of the drug-resistant tumor. ACS nano. 2016;10(3):3496–3508. doi:10.1021/acsnano.5b07706
   PubMed Web of Science ®Google Scholar
• You Y, Xu Z, Chen Y. Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer. Drug Delivery. 2018;25(1):448–460. doi:10.1080/10717544.2018.1435746
   PubMed Web of Science ®Google Scholar